← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2020-11-02

Drug application

FDA Application #
ANDA213278
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRINOTECAN HYDROCHLORIDE
Generic name
IRINOTECAN HYDROCHLORIDE
Active ingredients
IRINOTECAN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
EUGIA PHARMA
Manufacturer
Eugia US LLC
First approval
2020-11-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown